Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18.
about
Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccinationSafety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine in healthy Chinese females aged 15 to 45 years: a phase I trial.High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China.Comparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer.Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: an open-label phase I clinical trial.Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years.Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.No role for human papillomavirus in esophageal squamous cell carcinoma in China.Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial.Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trialHuman papillomavirus prevalence and type-distribution among women in Zhejiang Province, Southeast China: a cross-sectional study.Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study.Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China.Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China.Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest ChinaContribution from cancer epidemiological studies in china.Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, ChinaDoes HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance.Implementation of cervical cancer screening and prevention in China--challenges and reality.Prevalence of Human Papillomavirus Infection in Women in the Autonomous Region of Inner Mongolia: a Population-based Study of a Chinese Ethnic Minority.Comparison Between Two Detection Methods for HPV16, HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical CytologyCarcinogenic ability quantification of human papilloma virus subtypes in eastern China.Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination.Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer.Prevalence and genotype distribution of human papillomavirus infection among female sex workers in Guangxi, China: implications for interventions.Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis.
P2860
Q21261267-2A2A6C93-5246-4E3F-897A-2CA6F0F9B136Q33579684-091A4581-413E-4AE6-B3D5-5A2BC7D08CA1Q33735091-E38588CB-134C-45AF-B8F8-91B6A8E9E262Q33776653-74BFF761-4A49-443F-8CEA-66BEA69EBBDDQ34198635-20BCFCB9-35B4-428B-BE9C-C01C24B17CD3Q34290684-BBC0AA22-5976-47D6-A9CA-AEB37BC94F0FQ34291136-E338758D-338C-4591-A3B3-6C869B674D61Q34310582-BB2D495C-E291-4813-BCA7-EF67C6A1EC0FQ34756499-5E0ABFB0-0B11-442E-B911-D9E0871CDD08Q34776171-710B451D-F65C-4554-B9CB-71F83BFF9DAAQ34776205-1A28D692-E467-4C40-B64E-348BFE39BBA2Q34780744-BE63763F-13B0-4276-BD7B-952690C23800Q35006857-74FC514A-AD06-4F7A-865B-D59B10F95D8CQ35139997-6E1C7140-7F4F-477A-A7F5-CE53A012472EQ36183172-1E04DAAD-613F-44FC-8858-429631E06368Q36574466-E5854EF1-920C-41CE-B446-136F03EED192Q36654605-9CC38CFD-8C63-4F76-9FAD-72A3FF881B61Q37204991-74372A7B-D51D-46C1-BEAF-60D55628FEE4Q37983132-974B1234-B1DE-4F49-B27B-2EE794C820ACQ38268335-E6EF4570-80FE-4645-9045-FC42B551F0E8Q40141459-E8C9C8FE-4FCA-4B71-9C53-0B0B7398EB94Q40357072-D6640780-4721-4235-9EF7-4E8154CEDB30Q41139348-DB3D438E-39B9-463C-9E23-524235C986B0Q42197971-D7DD0BD5-0BF4-43C1-AEBC-03BBB79B5CE1Q42286778-6854B676-52BB-4657-B475-AB71B7604A80Q48003031-7B6C939E-2504-46C1-BB01-581C68AAE57DQ54974379-56613C45-8CCC-42BE-B68C-EB1C388F8496
P2860
Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human papillomavirus type-dist ...... e importance of HPV 16 and 18.
@en
Human papillomavirus type-dist ...... e importance of HPV 16 and 18.
@nl
type
label
Human papillomavirus type-dist ...... e importance of HPV 16 and 18.
@en
Human papillomavirus type-dist ...... e importance of HPV 16 and 18.
@nl
prefLabel
Human papillomavirus type-dist ...... e importance of HPV 16 and 18.
@en
Human papillomavirus type-dist ...... e importance of HPV 16 and 18.
@nl
P2093
P1476
Human papillomavirus type-dist ...... e importance of HPV 16 and 18.
@en
P2093
Anco Molijn
David Jenkins
Hong-Lin Zhou
Jennifer S Smith
Ji-Hong Liu
Jin-Feng Liu
Johannes E Schmidt
P2888
P304
P356
10.1007/S10552-009-9422-Z
P577
2009-08-25T00:00:00Z